Northwest Biotherapeutics (NWBO) Change in Cash (2010 - 2026)

Northwest Biotherapeutics' Change in Cash history runs 17 years deep, the most recent figure standing at -$1.3 million for Q1 2026.

• On a quarterly basis, Change in Cash fell 307.62% year-over-year to -$1.3 million in Q1 2026; TTM through Mar 2026 was -$993000.0, a 429.9% decrease from a year earlier, with the FY2025 full-year figure at $865000.0, up 1665.31% from the prior year.
• Change in Cash improved to -$1.3 million in Q1 2026 per NWBO's latest filing, from -$1.5 million in the prior quarter.
• Across five years, Change in Cash topped out at $4.7 million in Q3 2023 and bottomed at -$8.2 million in Q1 2022.
• The 5-year median for Change in Cash is -$764000.0 (2024), against an average of -$787235.3.
• Across the five-year window, Change in Cash soared 5789.74% in 2022 and slumped 307.62% in 2026, its largest moves.
• Year by year, Change in Cash stood at -$2.5 million in 2022, then plunged by 61.42% to -$4.0 million in 2023, then jumped by 80.76% to -$764000.0 in 2024, then plunged by 98.95% to -$1.5 million in 2025, then increased by 17.5% to -$1.3 million in 2026.
• Per Business Quant, the three latest NWBO Change in Cash figures stand at -$1.3 million (Q1 2026), -$1.5 million (Q4 2025), and $244000.0 (Q3 2025).